Lambrecht, S.; Liu, D.; Dzaye, O.; Kamson, D.O.; Reis, J.; Liebig, T.; Holdhoff, M.; Van Zijl, P.; Qin, Q.; Lin, D.D.M.
Velocity-Selective Arterial Spin Labeling Perfusion in Monitoring High Grade Gliomas Following Therapy: Clinical Feasibility at 1.5T and Comparison with Dynamic Susceptibility Contrast Perfusion. Brain Sci. 2024, 14, 126.
https://doi.org/10.3390/brainsci14020126
AMA Style
Lambrecht S, Liu D, Dzaye O, Kamson DO, Reis J, Liebig T, Holdhoff M, Van Zijl P, Qin Q, Lin DDM.
Velocity-Selective Arterial Spin Labeling Perfusion in Monitoring High Grade Gliomas Following Therapy: Clinical Feasibility at 1.5T and Comparison with Dynamic Susceptibility Contrast Perfusion. Brain Sciences. 2024; 14(2):126.
https://doi.org/10.3390/brainsci14020126
Chicago/Turabian Style
Lambrecht, Sebastian, Dapeng Liu, Omar Dzaye, David O. Kamson, Jonas Reis, Thomas Liebig, Matthias Holdhoff, Peter Van Zijl, Qin Qin, and Doris D. M. Lin.
2024. "Velocity-Selective Arterial Spin Labeling Perfusion in Monitoring High Grade Gliomas Following Therapy: Clinical Feasibility at 1.5T and Comparison with Dynamic Susceptibility Contrast Perfusion" Brain Sciences 14, no. 2: 126.
https://doi.org/10.3390/brainsci14020126
APA Style
Lambrecht, S., Liu, D., Dzaye, O., Kamson, D. O., Reis, J., Liebig, T., Holdhoff, M., Van Zijl, P., Qin, Q., & Lin, D. D. M.
(2024). Velocity-Selective Arterial Spin Labeling Perfusion in Monitoring High Grade Gliomas Following Therapy: Clinical Feasibility at 1.5T and Comparison with Dynamic Susceptibility Contrast Perfusion. Brain Sciences, 14(2), 126.
https://doi.org/10.3390/brainsci14020126